Different intraocular pressure-lowering effects of latanoprostene bunod across glaucoma subtypes: a 12-month real-world clinical study.

چکیده

To compare the reduction in intraocular pressure (IOP) over 12 months after switching from latanoprost to latanoprostene bunod (LBN) in different glaucoma subtypes, including primary open-angle glaucoma (POAG), pseudoexfoliation glaucoma (PXFG), and neovascular glaucoma (NVG), and to assess the…

متن کامل چکیده در سایت ناشر در دسترس است.

موضوعات مرتبط

• لنز داخل چشمی
• گلوکوم (آب سیاه)